SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Alvine Pharmaceuticals, Inc.'s ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch by Windhover Information Inc. for a Rare Second Year